These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12865391)

  • 1. Tolerance to vancomycin in a multiresistant, Colombian isolate of Streptococcus pneumoniae.
    Hidalgo M; Castaneda E; Arias CA
    J Antimicrob Chemother; 2003 Aug; 52(2):300-2. PubMed ID: 12865391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
    Henriques Normark B; Novak R; Ortqvist A; Källenius G; Tuomanen E; Normark S
    Clin Infect Dis; 2001 Feb; 32(4):552-8. PubMed ID: 11181117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriostatic or bactericidal effect of linezolid against multiresistant Streptococcus pneumoniae.
    Malm A; Korona-Głowniak I; Biernasiuk A; Kalasiewicz A; Juda M
    New Microbiol; 2008 Jul; 31(3):363-70. PubMed ID: 18843891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in a university hospital, Ankara, Turkey.
    Pinar A; Köseoğlu O; Yenişehirli G; Sener B
    Clin Microbiol Infect; 2004 Aug; 10(8):718-23. PubMed ID: 15301674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular characterization of Colombian invasive serotype 5 Streptococcus pneumoniae isolates recovered between 1994 and 2004].
    Firacative C; Moreno J; Castañeda E
    Biomedica; 2006 Jun; 26(2):295-301. PubMed ID: 16925102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children and multidrug resistance].
    Bayer M; Aslan G; Emekdaş G; Kuyucu N; Kanik A
    Mikrobiyol Bul; 2008 Apr; 42(2):223-30. PubMed ID: 18697420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of vancomycin tolerance in Streptococcus pneumoniae.
    Novak R; Henriques B; Charpentier E; Normark S; Tuomanen E
    Nature; 1999 Jun; 399(6736):590-3. PubMed ID: 10376600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillin and vancomycin tolerance among clinical isolates of Streptococcus pneumoniae in Hong Kong.
    Boost MV; Ko WM; O'Donoghue MM
    Hong Kong Med J; 2003 Dec; 9(6):415-8. PubMed ID: 14660808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.
    Ardanuy C; Rolo D; Fenoll A; Tarrago D; Calatayud L; Liñares J
    J Antimicrob Chemother; 2009 Sep; 64(3):507-10. PubMed ID: 19535383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections].
    Hernández M; Mejía GI; Trujillo H; Robledo J
    Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the molecule epidemiological between resistances of 7 genes interrelated 4 antibiotic to isolated Streptococcus pneumoniae in children].
    Ding YF; Mi ZH; Zhang JH; Tao YZ; Qin L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun; 26(6):435-9. PubMed ID: 16185459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in North Indian schoolchildren.
    Jain A; Kumar P; Awasthi S
    Trop Med Int Health; 2005 Mar; 10(3):234-9. PubMed ID: 15730507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
    Zhanel GG; Wang X; Nichol K; Nikulin A; Wierzbowski AK; Mulvey M; Hoban DJ
    Int J Antimicrob Agents; 2006 Nov; 28(5):465-71. PubMed ID: 17049211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of antibiotic resistance of the Spain14-5 Streptococcus pneumoniae clone over a 22 year period.
    Pérez-Trallero E; Marimón JM; Gonzalez A; Vicente D; García-Arenzana JM
    J Antimicrob Chemother; 2004 Apr; 53(4):620-5. PubMed ID: 14973156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
    Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
    J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Streptococcus pneumoniae: serotype evolution and patterns of antimicrobial susceptibility in invasive isolates from 11 years surveillance (1994 -2004) in Colombia].
    Agudelo CI; Moreno J; Sanabria OM; Ovalle MV; Di Fabio JL; Castañeda E;
    Biomedica; 2006 Jun; 26(2):234-49. PubMed ID: 16925096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact.
    Rodriguez CA; Atkinson R; Bitar W; Whitney CG; Edwards KM; Mitchell L; Li J; Sublett J; Li CS; Liu T; Chesney PJ; Tuomanen EI
    J Infect Dis; 2004 Oct; 190(8):1481-7. PubMed ID: 15378442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae.
    Deryke CA; Du X; Nicolau DP
    J Antimicrob Chemother; 2006 Sep; 58(3):601-9. PubMed ID: 16857688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.